Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;97(24):e11076.
doi: 10.1097/MD.0000000000011076.

Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review

Affiliations
Review

Management of hepatic vein occlusive disease after liver transplantation: A case report with literature review

Yuchen Hou et al. Medicine (Baltimore). 2018 Jun.

Abstract

Rationale: Hepatic vein occlusive disease (HVOD) is a rare complication after liver transplantation, which is characterized by nonthrombotic, fibrous obliteration of the small centrilobular hepatic veins by connective tissue and centrilobular necrosis in zone 3 of the acini. HVOD after solid organ transplantation has been reported; recently, most of these reports with limited cases have documented that acute cell rejection and immunosuppressive agents are the major causative factors. HVOD is relatively a rare complication of liver transplantation with the incidence of approximately 2%.

Patient concerns: A 59-year-old male patient with alcoholic liver cirrhosis underwent liver transplantation in our center. He suffered ascites, renal impairment 3 months after the surgery while liver enzymes were in normal range.

Diagnoses: Imagining and pathology showed no evidence of rejection or vessels complications. HVOD was diagnosed with pathology biopsy.

Interventions: Tacrolimus was withdrawn and the progression of HVOD was reversed.

Outcomes: Now, this patient has been followed up for 6 months after discharge with normal liver graft function.

Lessons: The use of tacrolimus in patients after liver transplantation may cause HVOD. Patients with jaundice, body weight gain, and refractory ascites should be strongly suspected of tacrolimus related HVOD.

PubMed Disclaimer

Figures

Figure 1
Figure 1
A 59-year-old male underwent liver transplantation. Hepatic hemodynamics at POD 11 were normal. (A) The large vessels in liver were unobstructed. (B) The blood flow returned to normal at POD 160.
Figure 2
Figure 2
The CT results of this patient. (A) The uneven reduction of hepatic density and there is no blood flow in hepatic vein and their branches. We withdrew tacrolimus after confirming the diagnosis of HVOD and the development of HVOD was reversed rapidly. (B) The redevelopment of hepatic vein.
Figure 3
Figure 3
The histologic results of this patient. (A) The central venous sinusoidal expansion around the regional congestion and atrophy or dissolved of liver cells. That can confirm the diagnosis of HVOD. (B) The normal structure of donor liver under the microscope after operation. The graft liver did not have HVOD before liver transplantation.

Similar articles

Cited by

References

    1. Senzolo M, Germani G, Cholongitas E, et al. Veno occlusive disease: update on clinical management. World J Gastroenterol 2007;13:3918–24. - PMC - PubMed
    1. Dignan FL, Wynn RF, Hadzic N, et al. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation. Br J Haematol 2013;163:444–57. - PubMed
    1. Wadleigh M, Ho V, Momtaz P, et al. Hepatic veno-occlusive disease: pathogenesis, diagnosis and treatment. Curr Opin Hematol 2003;10:451–62. - PubMed
    1. Stuart KL, Bras G. Veno-occlusive disease of the liver. Q J Med 1957;26:291–315. - PubMed
    1. Shulman HM, Gooley T, Dudley MD, et al. Utility of transvenous liver biopsies and wedged hepatic venous pressure measurements in sixty marrow transplant recipients. Transplantation 1995;59:1015–22. - PubMed